DE69925462D1 - Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande - Google Patents
Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligandeInfo
- Publication number
- DE69925462D1 DE69925462D1 DE69925462T DE69925462T DE69925462D1 DE 69925462 D1 DE69925462 D1 DE 69925462D1 DE 69925462 T DE69925462 T DE 69925462T DE 69925462 T DE69925462 T DE 69925462T DE 69925462 D1 DE69925462 D1 DE 69925462D1
- Authority
- DE
- Germany
- Prior art keywords
- oxonicotinic
- carboxamides
- compounds
- substituted cycloalkyl
- receptor ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7602298P | 1998-02-26 | 1998-02-26 | |
| US76022P | 1998-02-26 | ||
| PCT/US1999/004310 WO1999043661A2 (en) | 1998-02-26 | 1999-02-26 | Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69925462D1 true DE69925462D1 (de) | 2005-06-30 |
| DE69925462T2 DE69925462T2 (de) | 2006-02-02 |
Family
ID=22129452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69925462T Expired - Fee Related DE69925462T2 (de) | 1998-02-26 | 1999-02-26 | Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6194427B1 (de) |
| EP (1) | EP1056724B1 (de) |
| JP (1) | JP2002504544A (de) |
| AT (1) | ATE296290T1 (de) |
| AU (1) | AU2794099A (de) |
| BR (1) | BR9908321A (de) |
| CA (1) | CA2322167A1 (de) |
| DE (1) | DE69925462T2 (de) |
| ES (1) | ES2243046T3 (de) |
| WO (1) | WO1999043661A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764764B1 (en) * | 2003-05-23 | 2004-07-20 | Honeywell International Inc. | Polyethylene protective yarn |
| EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
| US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP1991212A1 (de) * | 2006-03-08 | 2008-11-19 | Braincells, Inc. | Neurogenesemodulation durch nootropika |
| MX2008014320A (es) * | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| EP2021000A2 (de) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenese mittels angiotensin-modulation |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| WO2007139818A2 (en) | 2006-05-22 | 2007-12-06 | The Board Of Trustees Of The Leland Stanford Junior University | Pharmacological treatment of cognitive impairment |
| EP2068872A1 (de) * | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Kombinationen mit einem 4-acylaminopyridin-derivat |
| EP2066355A2 (de) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Kombination aus einem durch einen peroxisom-proliferator aktivierten rezeptor-mittel und einem zweiten neurogenen mittel zur behandlung von erkrankungen des nervensystems sowie zur förderung von neuraler differenzierung und neurogenese |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US9089531B2 (en) | 2010-09-28 | 2015-07-28 | The Regents Of The University Of California | GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes |
| US8946206B2 (en) | 2010-12-17 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for improving cognitive function |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
| HU190796B (en) | 1981-06-12 | 1986-11-28 | Roussel Uclaf,Fr | Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives |
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| GB8425104D0 (en) | 1984-10-04 | 1984-11-07 | Ici America Inc | Amide derivatives |
| US4844732A (en) * | 1985-10-24 | 1989-07-04 | Daicel Chemical Industries Ltd. | Pyridine-3-carboxamide derivatives |
| JPS62167709A (ja) * | 1986-01-20 | 1987-07-24 | Daicel Chem Ind Ltd | 除草剤組成物 |
| JPH075559B2 (ja) * | 1986-04-23 | 1995-01-25 | ダイセル化学工業株式会社 | γ−ピリドン誘導体の製法 |
| US5750702A (en) * | 1993-10-27 | 1998-05-12 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
| AU2218997A (en) * | 1996-03-22 | 1997-10-10 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| US6177569B1 (en) | 1998-08-25 | 2001-01-23 | Neurogen Corporation | Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands |
-
1999
- 1999-02-26 US US09/259,244 patent/US6194427B1/en not_active Expired - Fee Related
- 1999-02-26 AU AU27940/99A patent/AU2794099A/en not_active Abandoned
- 1999-02-26 CA CA002322167A patent/CA2322167A1/en not_active Abandoned
- 1999-02-26 EP EP99908533A patent/EP1056724B1/de not_active Expired - Lifetime
- 1999-02-26 BR BR9908321-3A patent/BR9908321A/pt not_active Application Discontinuation
- 1999-02-26 JP JP2000533418A patent/JP2002504544A/ja active Pending
- 1999-02-26 DE DE69925462T patent/DE69925462T2/de not_active Expired - Fee Related
- 1999-02-26 WO PCT/US1999/004310 patent/WO1999043661A2/en active IP Right Grant
- 1999-02-26 AT AT99908533T patent/ATE296290T1/de not_active IP Right Cessation
- 1999-02-26 ES ES99908533T patent/ES2243046T3/es not_active Expired - Lifetime
-
2000
- 2000-05-05 US US09/565,531 patent/US6448259B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2243046T3 (es) | 2005-11-16 |
| WO1999043661A2 (en) | 1999-09-02 |
| US6448259B1 (en) | 2002-09-10 |
| JP2002504544A (ja) | 2002-02-12 |
| BR9908321A (pt) | 2001-12-18 |
| WO1999043661A3 (en) | 2000-01-06 |
| US6194427B1 (en) | 2001-02-27 |
| ATE296290T1 (de) | 2005-06-15 |
| DE69925462T2 (de) | 2006-02-02 |
| EP1056724A2 (de) | 2000-12-06 |
| EP1056724B1 (de) | 2005-05-25 |
| AU2794099A (en) | 1999-09-15 |
| CA2322167A1 (en) | 1999-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69925462D1 (de) | Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande | |
| OA09579A (en) | Certain imidazoquinoxalines a new class of gaba brain receptor ligands | |
| CA2175204A1 (en) | Certain Fused Pyrrolecarboxanilides; a New Class of GABA Brain Receptor Ligands | |
| DE60018274D1 (de) | Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden | |
| AU2321597A (en) | Novel imidazo{1,5-c}quinazolines; a new class of gaba brain receptor ligands | |
| BG102634A (en) | New condensated pyrolocarboxamides, a new class gaba receptor ligands in the brain | |
| YU10500A (sh) | Supstituisani 4-okso-naptiridin-3-karboksamidi kao gaba moždani receptorski liganidi | |
| MXPA03001344A (es) | Derivados de piridina 2,4-substituidos. | |
| ATE277927T1 (de) | Aryl- und heteroaryl-kondensierte aminoalkyl- imidazol-derivate: selektive modulatoren der gabaa-rezeptoren | |
| ATE341538T1 (de) | Benzimidazolonderivate mit affinität zu serotonin-und dopaminrezeptoren | |
| CA2223936A1 (en) | Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands | |
| ATE300539T1 (de) | Oxo-pyridoimidazol-carboxamide: gaba-rezeptor- liganden im gehirn | |
| MX9709771A (es) | Nuevas aril y cicloalquil imidazolonas substituidas, una clase de ligandos receptores de acido gamma-aminobutirico del cerebro. | |
| CA2249562A1 (en) | Certain fused pyrrolecarboxamides as gaba brain receptor ligands | |
| MY107732A (en) | Certain imidazoquinoxalines; a new class of gaba brain receptor ligands. | |
| DK1192161T3 (da) | Chromeno[4,3,2-de]isoquinoliner som kraftige dopaminreceptorligander | |
| YU35292A (sh) | Izvesni imidazohinoksalini nova klasa gaba moždanih receptorskih liganada | |
| AR009786A1 (es) | Pirrolcarboxamidas fusionadas, una nueva clase de ligandos receptores cerebrales gaba | |
| TH42836A (th) | ซับสทิทิวเทด 4-ออกโซ-แนฟธิริดีน-3-คาร์บอกแซมีด; gaba เบรน รีเซปเตอร์ ลิแกนด์ | |
| AR007742A1 (es) | Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro. | |
| UY23469A1 (es) | Ciertas imidazoquinoxalinas: una nueva clase de ligantes de receptores cerebrales de gaba |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |